MiRNA-363-3p/DUSP10/JNK axis mediates chemoresistance by enhancing DNA damage repair in diffuse large B-cell lymphoma.
MiRNA-363-3p/DUSP10/JNK axis mediates chemoresistance by enhancing DNA damage repair in diffuse large B-cell lymphoma.
复制标题
miRNA-363-3p/dusp10/jnk轴通过增强弥漫性大型B细胞淋巴瘤中的DNA损伤修复来介导化学抗性。
DOI:
10.1038/s41375-022-01565-6
复制
发表时间:
2022-07
期刊:
影响因子:
11.4
通讯作者:
Liu, Yanyan
中科院分区:
文献类型:
--
作者:
Zhou, Wenping;Xu, Yuanlin;Zhang, Jiuyang;Zhang, Peipei;Yao, Zhihua;Yan, Zheng;Wang, Haiying;Chu, Junfeng;Yao, Shuna;Zhao, Shuang;Yang, Shujun;Guo, Yongjun;Miao, Jinxin;Liu, Kangdong;Chan, Wing C.;Xia, Qingxin;Liu, Yanyan
Anthracycline-based chemotherapy resistance represents a major challenge in diffuse large B-cell lymphoma (DLBCL). MiRNA and gene expression profiles (n = 47) were determined to uncover potential chemoresistance mechanisms and therapeutic approaches. An independent correlation between high expression of miRNA-363-3p and chemoresistance was observed and validated in a larger cohort (n = 106). MiRNA-363-3p was shown to reduce doxorubicin-induced apoptosis and tumor shrinkage in in vitro and in vivo experiments by ectopic expression and CRISPR/Cas9-mediated knockout in DLBCL cell lines. DNA methylation was found to participate in transcriptional regulation of miRNA-363-3p. Further investigation revealed that dual specificity phosphatase 10 (DUSP10) is a target of miRNA-363-3p and its suppression promotes the phosphorylation of c-Jun N-terminal kinase (JNK). The miRNA-363-3p/DUSP10/JNK axis was predominantly associated with negative regulation of homologous recombination (HR) and DNA repair pathways. Ectopic expression of miRNA-363-3p more effectively repaired doxorubicin-induced double-strand break (DSB) while enhancing non-homologous end joining repair and reducing HR repair. Targeting JNK and poly (ADP-ribose) polymerase 1 significantly inhibited doxorubicin-induced DSB repair, increased doxorubicin-induced cell apoptosis and tumor shrinkage, and improved the survival of tumor-bearing mice. In conclusion, the miRNA-363-3p/DUSP10/JNK axis is a novel chemoresistance mechanism in DLBCL that may be reversed by targeted therapy.
登录
查看更多内容
影响因子:
5.3
作者:
Lu, Xiaoqing;Chen, Jun;Lossos, Izidore S.
通讯作者:
Lossos, Izidore S.
影响因子:
82.9
作者:
Chapuy B;Stewart C;Dunford AJ;Kim J;Kamburov A;Redd RA;Lawrence MS;Roemer MGM;Li AJ;Ziepert M;Staiger AM;Wala JA;Ducar MD;Leshchiner I;Rheinbay E;Taylor-Weiner A;Coughlin CA;Hess JM;Pedamallu CS;Livitz D;Rosebrock D;Rosenberg M;Tracy AA;Horn H;van Hummelen P;Feldman AL;Link BK;Novak AJ;Cerhan JR;Habermann TM;Siebert R;Rosenwald A;Thorner AR;Meyerson ML;Golub TR;Beroukhim R;Wulf GG;Ott G;Rodig SJ;Monti S;Neuberg DS;Loeffler M;Pfreundschuh M;Trümper L;Getz G;Shipp MA
通讯作者:
Shipp MA
影响因子:
64.8
作者:
Alizadeh, AA;Eisen, MB;Staudt, LM
通讯作者:
Staudt, LM
影响因子:
20.3
作者:
Li, Yong;Gordon, Michael W.;Young, Ken H.
通讯作者:
Young, Ken H.
影响因子:
14.9
作者:
Kuhar R;Gwiazda KS;Humbert O;Mandt T;Pangallo J;Brault M;Khan I;Maizels N;Rawlings DJ;Scharenberg AM;Certo MT
通讯作者:
Certo MT